nodes	percent_of_prediction	percent_of_DWPC	metapath
Darunavir—CYP3A4—Thiotepa—urinary bladder cancer	0.168	0.687	CbGbCtD
Darunavir—CYP3A4—Etoposide—urinary bladder cancer	0.0455	0.186	CbGbCtD
Darunavir—CYP3A4—Doxorubicin—urinary bladder cancer	0.031	0.127	CbGbCtD
Darunavir—Bradycardia—Epirubicin—urinary bladder cancer	0.000421	0.000556	CcSEcCtD
Darunavir—Diarrhoea—Gemcitabine—urinary bladder cancer	0.00042	0.000555	CcSEcCtD
Darunavir—Renal failure—Doxorubicin—urinary bladder cancer	0.000419	0.000554	CcSEcCtD
Darunavir—Erythema multiforme—Methotrexate—urinary bladder cancer	0.000417	0.000552	CcSEcCtD
Darunavir—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	0.000417	0.000552	CcSEcCtD
Darunavir—Urticaria—Etoposide—urinary bladder cancer	0.000416	0.00055	CcSEcCtD
Darunavir—Haemoglobin—Epirubicin—urinary bladder cancer	0.000415	0.000549	CcSEcCtD
Darunavir—Stomatitis—Doxorubicin—urinary bladder cancer	0.000415	0.000549	CcSEcCtD
Darunavir—Jaundice—Doxorubicin—urinary bladder cancer	0.000415	0.000549	CcSEcCtD
Darunavir—Abdominal pain—Etoposide—urinary bladder cancer	0.000414	0.000548	CcSEcCtD
Darunavir—Body temperature increased—Etoposide—urinary bladder cancer	0.000414	0.000548	CcSEcCtD
Darunavir—Haemorrhage—Epirubicin—urinary bladder cancer	0.000413	0.000547	CcSEcCtD
Darunavir—Hepatitis—Epirubicin—urinary bladder cancer	0.000413	0.000547	CcSEcCtD
Darunavir—Eye disorder—Methotrexate—urinary bladder cancer	0.000413	0.000546	CcSEcCtD
Darunavir—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000412	0.000546	CcSEcCtD
Darunavir—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.000411	0.000544	CcSEcCtD
Darunavir—Asthenia—Cisplatin—urinary bladder cancer	0.00041	0.000543	CcSEcCtD
Darunavir—Cardiac disorder—Methotrexate—urinary bladder cancer	0.00041	0.000542	CcSEcCtD
Darunavir—Urinary tract disorder—Epirubicin—urinary bladder cancer	0.000408	0.00054	CcSEcCtD
Darunavir—Oedema peripheral—Epirubicin—urinary bladder cancer	0.000407	0.000538	CcSEcCtD
Darunavir—Haematuria—Doxorubicin—urinary bladder cancer	0.000406	0.000537	CcSEcCtD
Darunavir—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.000406	0.000537	CcSEcCtD
Darunavir—Urethral disorder—Epirubicin—urinary bladder cancer	0.000405	0.000536	CcSEcCtD
Darunavir—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.000403	0.000533	CcSEcCtD
Darunavir—Epistaxis—Doxorubicin—urinary bladder cancer	0.000402	0.000531	CcSEcCtD
Darunavir—Angiopathy—Methotrexate—urinary bladder cancer	0.0004	0.00053	CcSEcCtD
Darunavir—Immune system disorder—Methotrexate—urinary bladder cancer	0.000399	0.000528	CcSEcCtD
Darunavir—Dizziness—Fluorouracil—urinary bladder cancer	0.000399	0.000527	CcSEcCtD
Darunavir—Visual impairment—Epirubicin—urinary bladder cancer	0.000398	0.000527	CcSEcCtD
Darunavir—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000398	0.000526	CcSEcCtD
Darunavir—Chills—Methotrexate—urinary bladder cancer	0.000396	0.000524	CcSEcCtD
Darunavir—Diarrhoea—Cisplatin—urinary bladder cancer	0.000391	0.000517	CcSEcCtD
Darunavir—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000391	0.000517	CcSEcCtD
Darunavir—Alopecia—Methotrexate—urinary bladder cancer	0.00039	0.000516	CcSEcCtD
Darunavir—Vomiting—Gemcitabine—urinary bladder cancer	0.00039	0.000516	CcSEcCtD
Darunavir—Bradycardia—Doxorubicin—urinary bladder cancer	0.000389	0.000515	CcSEcCtD
Darunavir—Mental disorder—Methotrexate—urinary bladder cancer	0.000387	0.000512	CcSEcCtD
Darunavir—Rash—Gemcitabine—urinary bladder cancer	0.000387	0.000511	CcSEcCtD
Darunavir—Dermatitis—Gemcitabine—urinary bladder cancer	0.000386	0.000511	CcSEcCtD
Darunavir—Eye disorder—Epirubicin—urinary bladder cancer	0.000386	0.000511	CcSEcCtD
Darunavir—Hypersensitivity—Etoposide—urinary bladder cancer	0.000386	0.00051	CcSEcCtD
Darunavir—Erythema—Methotrexate—urinary bladder cancer	0.000384	0.000508	CcSEcCtD
Darunavir—Malnutrition—Methotrexate—urinary bladder cancer	0.000384	0.000508	CcSEcCtD
Darunavir—Haemoglobin—Doxorubicin—urinary bladder cancer	0.000384	0.000508	CcSEcCtD
Darunavir—Headache—Gemcitabine—urinary bladder cancer	0.000384	0.000508	CcSEcCtD
Darunavir—Flushing—Epirubicin—urinary bladder cancer	0.000383	0.000507	CcSEcCtD
Darunavir—Cardiac disorder—Epirubicin—urinary bladder cancer	0.000383	0.000507	CcSEcCtD
Darunavir—Vomiting—Fluorouracil—urinary bladder cancer	0.000383	0.000507	CcSEcCtD
Darunavir—Haemorrhage—Doxorubicin—urinary bladder cancer	0.000382	0.000506	CcSEcCtD
Darunavir—Hepatitis—Doxorubicin—urinary bladder cancer	0.000382	0.000506	CcSEcCtD
Darunavir—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.00038	0.000503	CcSEcCtD
Darunavir—Rash—Fluorouracil—urinary bladder cancer	0.00038	0.000503	CcSEcCtD
Darunavir—Dermatitis—Fluorouracil—urinary bladder cancer	0.00038	0.000502	CcSEcCtD
Darunavir—Headache—Fluorouracil—urinary bladder cancer	0.000378	0.0005	CcSEcCtD
Darunavir—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.000377	0.000499	CcSEcCtD
Darunavir—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000377	0.000498	CcSEcCtD
Darunavir—Dysgeusia—Methotrexate—urinary bladder cancer	0.000376	0.000498	CcSEcCtD
Darunavir—Asthenia—Etoposide—urinary bladder cancer	0.000376	0.000497	CcSEcCtD
Darunavir—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.000376	0.000497	CcSEcCtD
Darunavir—Angiopathy—Epirubicin—urinary bladder cancer	0.000375	0.000496	CcSEcCtD
Darunavir—Urethral disorder—Doxorubicin—urinary bladder cancer	0.000375	0.000496	CcSEcCtD
Darunavir—Immune system disorder—Epirubicin—urinary bladder cancer	0.000373	0.000494	CcSEcCtD
Darunavir—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000372	0.000493	CcSEcCtD
Darunavir—Chills—Epirubicin—urinary bladder cancer	0.000371	0.00049	CcSEcCtD
Darunavir—Pruritus—Etoposide—urinary bladder cancer	0.00037	0.00049	CcSEcCtD
Darunavir—Visual impairment—Doxorubicin—urinary bladder cancer	0.000368	0.000487	CcSEcCtD
Darunavir—Alopecia—Epirubicin—urinary bladder cancer	0.000365	0.000483	CcSEcCtD
Darunavir—Nausea—Gemcitabine—urinary bladder cancer	0.000364	0.000482	CcSEcCtD
Darunavir—Vomiting—Cisplatin—urinary bladder cancer	0.000363	0.000481	CcSEcCtD
Darunavir—Mental disorder—Epirubicin—urinary bladder cancer	0.000362	0.000479	CcSEcCtD
Darunavir—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000361	0.000478	CcSEcCtD
Darunavir—Rash—Cisplatin—urinary bladder cancer	0.00036	0.000477	CcSEcCtD
Darunavir—Dermatitis—Cisplatin—urinary bladder cancer	0.00036	0.000476	CcSEcCtD
Darunavir—Erythema—Epirubicin—urinary bladder cancer	0.00036	0.000476	CcSEcCtD
Darunavir—Malnutrition—Epirubicin—urinary bladder cancer	0.00036	0.000476	CcSEcCtD
Darunavir—Diarrhoea—Etoposide—urinary bladder cancer	0.000358	0.000474	CcSEcCtD
Darunavir—Nausea—Fluorouracil—urinary bladder cancer	0.000358	0.000474	CcSEcCtD
Darunavir—Eye disorder—Doxorubicin—urinary bladder cancer	0.000357	0.000473	CcSEcCtD
Darunavir—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000357	0.000472	CcSEcCtD
Darunavir—Anaemia—Methotrexate—urinary bladder cancer	0.000355	0.00047	CcSEcCtD
Darunavir—Flushing—Doxorubicin—urinary bladder cancer	0.000355	0.000469	CcSEcCtD
Darunavir—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000355	0.000469	CcSEcCtD
Darunavir—Flatulence—Epirubicin—urinary bladder cancer	0.000354	0.000469	CcSEcCtD
Darunavir—Dysgeusia—Epirubicin—urinary bladder cancer	0.000352	0.000466	CcSEcCtD
Darunavir—Angiopathy—Doxorubicin—urinary bladder cancer	0.000347	0.000459	CcSEcCtD
Darunavir—Malaise—Methotrexate—urinary bladder cancer	0.000347	0.000458	CcSEcCtD
Darunavir—Dizziness—Etoposide—urinary bladder cancer	0.000346	0.000458	CcSEcCtD
Darunavir—Muscle spasms—Epirubicin—urinary bladder cancer	0.000346	0.000457	CcSEcCtD
Darunavir—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000345	0.000457	CcSEcCtD
Darunavir—Vertigo—Methotrexate—urinary bladder cancer	0.000345	0.000457	CcSEcCtD
Darunavir—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.000344	0.000456	CcSEcCtD
Darunavir—Leukopenia—Methotrexate—urinary bladder cancer	0.000344	0.000455	CcSEcCtD
Darunavir—Chills—Doxorubicin—urinary bladder cancer	0.000343	0.000454	CcSEcCtD
Darunavir—Nausea—Cisplatin—urinary bladder cancer	0.000339	0.000449	CcSEcCtD
Darunavir—Alopecia—Doxorubicin—urinary bladder cancer	0.000338	0.000447	CcSEcCtD
Darunavir—Cough—Methotrexate—urinary bladder cancer	0.000335	0.000444	CcSEcCtD
Darunavir—Mental disorder—Doxorubicin—urinary bladder cancer	0.000335	0.000443	CcSEcCtD
Darunavir—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000334	0.000441	CcSEcCtD
Darunavir—Convulsion—Methotrexate—urinary bladder cancer	0.000333	0.00044	CcSEcCtD
Darunavir—Vomiting—Etoposide—urinary bladder cancer	0.000333	0.00044	CcSEcCtD
Darunavir—Malnutrition—Doxorubicin—urinary bladder cancer	0.000333	0.00044	CcSEcCtD
Darunavir—Erythema—Doxorubicin—urinary bladder cancer	0.000333	0.00044	CcSEcCtD
Darunavir—Anaemia—Epirubicin—urinary bladder cancer	0.000332	0.00044	CcSEcCtD
Darunavir—Agitation—Epirubicin—urinary bladder cancer	0.00033	0.000437	CcSEcCtD
Darunavir—Rash—Etoposide—urinary bladder cancer	0.00033	0.000437	CcSEcCtD
Darunavir—Dermatitis—Etoposide—urinary bladder cancer	0.00033	0.000436	CcSEcCtD
Darunavir—Headache—Etoposide—urinary bladder cancer	0.000328	0.000434	CcSEcCtD
Darunavir—Flatulence—Doxorubicin—urinary bladder cancer	0.000328	0.000434	CcSEcCtD
Darunavir—Chest pain—Methotrexate—urinary bladder cancer	0.000327	0.000433	CcSEcCtD
Darunavir—Arthralgia—Methotrexate—urinary bladder cancer	0.000327	0.000433	CcSEcCtD
Darunavir—Myalgia—Methotrexate—urinary bladder cancer	0.000327	0.000433	CcSEcCtD
Darunavir—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000326	0.000431	CcSEcCtD
Darunavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000325	0.00043	CcSEcCtD
Darunavir—Malaise—Epirubicin—urinary bladder cancer	0.000324	0.000429	CcSEcCtD
Darunavir—Discomfort—Methotrexate—urinary bladder cancer	0.000323	0.000428	CcSEcCtD
Darunavir—Vertigo—Epirubicin—urinary bladder cancer	0.000323	0.000427	CcSEcCtD
Darunavir—Syncope—Epirubicin—urinary bladder cancer	0.000322	0.000427	CcSEcCtD
Darunavir—Leukopenia—Epirubicin—urinary bladder cancer	0.000322	0.000426	CcSEcCtD
Darunavir—Muscle spasms—Doxorubicin—urinary bladder cancer	0.00032	0.000423	CcSEcCtD
Darunavir—Palpitations—Epirubicin—urinary bladder cancer	0.000318	0.00042	CcSEcCtD
Darunavir—Confusional state—Methotrexate—urinary bladder cancer	0.000316	0.000418	CcSEcCtD
Darunavir—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000316	0.000418	CcSEcCtD
Darunavir—Cough—Epirubicin—urinary bladder cancer	0.000314	0.000415	CcSEcCtD
Darunavir—Convulsion—Epirubicin—urinary bladder cancer	0.000312	0.000412	CcSEcCtD
Darunavir—Nausea—Etoposide—urinary bladder cancer	0.000311	0.000411	CcSEcCtD
Darunavir—Hypertension—Epirubicin—urinary bladder cancer	0.00031	0.000411	CcSEcCtD
Darunavir—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000309	0.000408	CcSEcCtD
Darunavir—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000308	0.000407	CcSEcCtD
Darunavir—Anaemia—Doxorubicin—urinary bladder cancer	0.000308	0.000407	CcSEcCtD
Darunavir—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000307	0.000406	CcSEcCtD
Darunavir—Chest pain—Epirubicin—urinary bladder cancer	0.000306	0.000405	CcSEcCtD
Darunavir—Arthralgia—Epirubicin—urinary bladder cancer	0.000306	0.000405	CcSEcCtD
Darunavir—Myalgia—Epirubicin—urinary bladder cancer	0.000306	0.000405	CcSEcCtD
Darunavir—Agitation—Doxorubicin—urinary bladder cancer	0.000306	0.000405	CcSEcCtD
Darunavir—Anxiety—Epirubicin—urinary bladder cancer	0.000305	0.000404	CcSEcCtD
Darunavir—Skin disorder—Methotrexate—urinary bladder cancer	0.000305	0.000403	CcSEcCtD
Darunavir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000304	0.000402	CcSEcCtD
Darunavir—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000303	0.000401	CcSEcCtD
Darunavir—Discomfort—Epirubicin—urinary bladder cancer	0.000302	0.0004	CcSEcCtD
Darunavir—Malaise—Doxorubicin—urinary bladder cancer	0.0003	0.000397	CcSEcCtD
Darunavir—Dry mouth—Epirubicin—urinary bladder cancer	0.000299	0.000396	CcSEcCtD
Darunavir—Vertigo—Doxorubicin—urinary bladder cancer	0.000299	0.000396	CcSEcCtD
Darunavir—Anorexia—Methotrexate—urinary bladder cancer	0.000299	0.000396	CcSEcCtD
Darunavir—Syncope—Doxorubicin—urinary bladder cancer	0.000298	0.000395	CcSEcCtD
Darunavir—Leukopenia—Doxorubicin—urinary bladder cancer	0.000298	0.000394	CcSEcCtD
Darunavir—Confusional state—Epirubicin—urinary bladder cancer	0.000296	0.000392	CcSEcCtD
Darunavir—Palpitations—Doxorubicin—urinary bladder cancer	0.000294	0.000389	CcSEcCtD
Darunavir—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000292	0.000387	CcSEcCtD
Darunavir—Cough—Doxorubicin—urinary bladder cancer	0.00029	0.000384	CcSEcCtD
Darunavir—Shock—Epirubicin—urinary bladder cancer	0.000289	0.000382	CcSEcCtD
Darunavir—Convulsion—Doxorubicin—urinary bladder cancer	0.000288	0.000381	CcSEcCtD
Darunavir—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000288	0.000381	CcSEcCtD
Darunavir—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000287	0.00038	CcSEcCtD
Darunavir—Hypertension—Doxorubicin—urinary bladder cancer	0.000287	0.00038	CcSEcCtD
Darunavir—Tachycardia—Epirubicin—urinary bladder cancer	0.000286	0.000379	CcSEcCtD
Darunavir—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000286	0.000378	CcSEcCtD
Darunavir—Skin disorder—Epirubicin—urinary bladder cancer	0.000285	0.000377	CcSEcCtD
Darunavir—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000284	0.000375	CcSEcCtD
Darunavir—Insomnia—Methotrexate—urinary bladder cancer	0.000284	0.000375	CcSEcCtD
Darunavir—Arthralgia—Doxorubicin—urinary bladder cancer	0.000283	0.000375	CcSEcCtD
Darunavir—Chest pain—Doxorubicin—urinary bladder cancer	0.000283	0.000375	CcSEcCtD
Darunavir—Myalgia—Doxorubicin—urinary bladder cancer	0.000283	0.000375	CcSEcCtD
Darunavir—Anxiety—Doxorubicin—urinary bladder cancer	0.000282	0.000373	CcSEcCtD
Darunavir—Paraesthesia—Methotrexate—urinary bladder cancer	0.000282	0.000373	CcSEcCtD
Darunavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000281	0.000372	CcSEcCtD
Darunavir—Discomfort—Doxorubicin—urinary bladder cancer	0.00028	0.00037	CcSEcCtD
Darunavir—Anorexia—Epirubicin—urinary bladder cancer	0.00028	0.00037	CcSEcCtD
Darunavir—Dyspnoea—Methotrexate—urinary bladder cancer	0.00028	0.00037	CcSEcCtD
Darunavir—Somnolence—Methotrexate—urinary bladder cancer	0.000279	0.000369	CcSEcCtD
Darunavir—Dry mouth—Doxorubicin—urinary bladder cancer	0.000277	0.000367	CcSEcCtD
Darunavir—Dyspepsia—Methotrexate—urinary bladder cancer	0.000276	0.000365	CcSEcCtD
Darunavir—Confusional state—Doxorubicin—urinary bladder cancer	0.000274	0.000362	CcSEcCtD
Darunavir—Decreased appetite—Methotrexate—urinary bladder cancer	0.000273	0.000361	CcSEcCtD
Darunavir—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000271	0.000358	CcSEcCtD
Darunavir—Fatigue—Methotrexate—urinary bladder cancer	0.00027	0.000358	CcSEcCtD
Darunavir—Pain—Methotrexate—urinary bladder cancer	0.000268	0.000355	CcSEcCtD
Darunavir—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000267	0.000354	CcSEcCtD
Darunavir—Shock—Doxorubicin—urinary bladder cancer	0.000267	0.000353	CcSEcCtD
Darunavir—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000266	0.000352	CcSEcCtD
Darunavir—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000266	0.000352	CcSEcCtD
Darunavir—Insomnia—Epirubicin—urinary bladder cancer	0.000265	0.000351	CcSEcCtD
Darunavir—Tachycardia—Doxorubicin—urinary bladder cancer	0.000265	0.000351	CcSEcCtD
Darunavir—Skin disorder—Doxorubicin—urinary bladder cancer	0.000264	0.000349	CcSEcCtD
Darunavir—Paraesthesia—Epirubicin—urinary bladder cancer	0.000264	0.000349	CcSEcCtD
Darunavir—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000263	0.000347	CcSEcCtD
Darunavir—Dyspnoea—Epirubicin—urinary bladder cancer	0.000262	0.000346	CcSEcCtD
Darunavir—Somnolence—Epirubicin—urinary bladder cancer	0.000261	0.000345	CcSEcCtD
Darunavir—Anorexia—Doxorubicin—urinary bladder cancer	0.000259	0.000342	CcSEcCtD
Darunavir—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000258	0.000342	CcSEcCtD
Darunavir—Dyspepsia—Epirubicin—urinary bladder cancer	0.000258	0.000342	CcSEcCtD
Darunavir—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000256	0.000339	CcSEcCtD
Darunavir—Decreased appetite—Epirubicin—urinary bladder cancer	0.000255	0.000338	CcSEcCtD
Darunavir—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000253	0.000335	CcSEcCtD
Darunavir—Fatigue—Epirubicin—urinary bladder cancer	0.000253	0.000335	CcSEcCtD
Darunavir—Pain—Epirubicin—urinary bladder cancer	0.000251	0.000332	CcSEcCtD
Darunavir—Constipation—Epirubicin—urinary bladder cancer	0.000251	0.000332	CcSEcCtD
Darunavir—Urticaria—Methotrexate—urinary bladder cancer	0.000249	0.00033	CcSEcCtD
Darunavir—Abdominal pain—Methotrexate—urinary bladder cancer	0.000248	0.000328	CcSEcCtD
Darunavir—Body temperature increased—Methotrexate—urinary bladder cancer	0.000248	0.000328	CcSEcCtD
Darunavir—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000247	0.000327	CcSEcCtD
Darunavir—Insomnia—Doxorubicin—urinary bladder cancer	0.000246	0.000325	CcSEcCtD
Darunavir—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000244	0.000323	CcSEcCtD
Darunavir—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000242	0.00032	CcSEcCtD
Darunavir—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000242	0.00032	CcSEcCtD
Darunavir—Somnolence—Doxorubicin—urinary bladder cancer	0.000241	0.000319	CcSEcCtD
Darunavir—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.00024	0.000318	CcSEcCtD
Darunavir—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000239	0.000316	CcSEcCtD
Darunavir—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000236	0.000312	CcSEcCtD
Darunavir—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000234	0.00031	CcSEcCtD
Darunavir—Fatigue—Doxorubicin—urinary bladder cancer	0.000234	0.00031	CcSEcCtD
Darunavir—Urticaria—Epirubicin—urinary bladder cancer	0.000233	0.000308	CcSEcCtD
Darunavir—Pain—Doxorubicin—urinary bladder cancer	0.000232	0.000307	CcSEcCtD
Darunavir—Constipation—Doxorubicin—urinary bladder cancer	0.000232	0.000307	CcSEcCtD
Darunavir—Abdominal pain—Epirubicin—urinary bladder cancer	0.000232	0.000307	CcSEcCtD
Darunavir—Body temperature increased—Epirubicin—urinary bladder cancer	0.000232	0.000307	CcSEcCtD
Darunavir—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000231	0.000306	CcSEcCtD
Darunavir—Asthenia—Methotrexate—urinary bladder cancer	0.000225	0.000298	CcSEcCtD
Darunavir—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000224	0.000296	CcSEcCtD
Darunavir—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000222	0.000294	CcSEcCtD
Darunavir—Pruritus—Methotrexate—urinary bladder cancer	0.000222	0.000294	CcSEcCtD
Darunavir—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000216	0.000286	CcSEcCtD
Darunavir—Urticaria—Doxorubicin—urinary bladder cancer	0.000216	0.000285	CcSEcCtD
Darunavir—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000215	0.000284	CcSEcCtD
Darunavir—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000215	0.000284	CcSEcCtD
Darunavir—Diarrhoea—Methotrexate—urinary bladder cancer	0.000215	0.000284	CcSEcCtD
Darunavir—Asthenia—Epirubicin—urinary bladder cancer	0.000211	0.000279	CcSEcCtD
Darunavir—Pruritus—Epirubicin—urinary bladder cancer	0.000208	0.000275	CcSEcCtD
Darunavir—Dizziness—Methotrexate—urinary bladder cancer	0.000207	0.000274	CcSEcCtD
Darunavir—Diarrhoea—Epirubicin—urinary bladder cancer	0.000201	0.000266	CcSEcCtD
Darunavir—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.0002	0.000265	CcSEcCtD
Darunavir—Vomiting—Methotrexate—urinary bladder cancer	0.000199	0.000264	CcSEcCtD
Darunavir—Rash—Methotrexate—urinary bladder cancer	0.000198	0.000262	CcSEcCtD
Darunavir—Dermatitis—Methotrexate—urinary bladder cancer	0.000198	0.000261	CcSEcCtD
Darunavir—Headache—Methotrexate—urinary bladder cancer	0.000196	0.00026	CcSEcCtD
Darunavir—Asthenia—Doxorubicin—urinary bladder cancer	0.000195	0.000258	CcSEcCtD
Darunavir—Dizziness—Epirubicin—urinary bladder cancer	0.000194	0.000257	CcSEcCtD
Darunavir—Pruritus—Doxorubicin—urinary bladder cancer	0.000192	0.000254	CcSEcCtD
Darunavir—Vomiting—Epirubicin—urinary bladder cancer	0.000187	0.000247	CcSEcCtD
Darunavir—Nausea—Methotrexate—urinary bladder cancer	0.000186	0.000246	CcSEcCtD
Darunavir—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000186	0.000246	CcSEcCtD
Darunavir—Rash—Epirubicin—urinary bladder cancer	0.000185	0.000245	CcSEcCtD
Darunavir—Dermatitis—Epirubicin—urinary bladder cancer	0.000185	0.000245	CcSEcCtD
Darunavir—Headache—Epirubicin—urinary bladder cancer	0.000184	0.000243	CcSEcCtD
Darunavir—Dizziness—Doxorubicin—urinary bladder cancer	0.00018	0.000238	CcSEcCtD
Darunavir—Nausea—Epirubicin—urinary bladder cancer	0.000174	0.000231	CcSEcCtD
Darunavir—Vomiting—Doxorubicin—urinary bladder cancer	0.000173	0.000228	CcSEcCtD
Darunavir—Rash—Doxorubicin—urinary bladder cancer	0.000171	0.000227	CcSEcCtD
Darunavir—Dermatitis—Doxorubicin—urinary bladder cancer	0.000171	0.000226	CcSEcCtD
Darunavir—Headache—Doxorubicin—urinary bladder cancer	0.00017	0.000225	CcSEcCtD
Darunavir—Nausea—Doxorubicin—urinary bladder cancer	0.000161	0.000213	CcSEcCtD
